Publikationen des AMSP-Projektes
Hier finden Sie eine Auflistung der zahlreichen Publikationen des AMSP-Projektes. Ziel unserer Publikationen von Einzelfällen, Fallreihen und statistischen Auswertungen ist es, das im AMSP-Projekt gesammelte Wissen zu unerwünschten Wirkungen von Psychopharmaka und Risikozusammenhängen der Fachwelt zugänglich zu machen und so im internationalen wissenschaftlichen Diskurs die Behandlungsqualität psychisch erkrankter Menschen zu verbessern.
Greil W, de Bardeci M, Müller-Oerlinghausen B, Nievergelt N, Stassen H, Hasler G, Erfurth A, Cattapan K, Rüther E, Seifert J, Toto S, Bleich S, Schoretsanitis G. Controversies regarding lithium-associated weight gain: case-control study of real-world drug safety data. Int J Bipolar Disord. 2023 Oct 15;11(1):34. doi: 10.1186/s40345-023-00313-8.
Engel J, Haack B, Zolk O, Greiner T, Heinze M, Toto S, Seifert J, Bleich S, Glocker C, Grohmann R, Schneider M, Stübner S. Edema related to treatment with psychotropic drugs. J Neural Transm (Vienna). 2024 Mar;131(3):253-266. doi: 10.1007/s00702-024-02738-6.
Glocker C, Grohmann R, Burkhardt G, Seifert J, Bleich S, Held T, Toto S, Stübner S, Schüle C. Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016. J Neural Transm (Vienna). 2023 Feb;130(2):153-163. doi: 10.1007/s00702-023-02589-7.
Seifert J, Letmaier M, Greiner T, Schneider M, Deest M, Eberlein CK, Bleich S, Grohmann R, Toto S. Psychotropic drug-induced hyponatremia: results from a drug surveillance program-an update. J Neural Transm (Vienna). 2021 Aug;128(8):1249-1264. doi: 10.1007/s00702-021-02369-1.
de Bardeci M, Greil W, Stassen H, Willms J, Köberle U, Bridler R, Hasler G, Kasper S, Rüther E, Bleich S, Toto S, Grohmann R, Seifert J. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data. Eur Arch Psychiatry Clin Neurosci. 2023 Feb;273(1):65-74. doi: 10.1007/s00406-022-01392-x.
Seifert J, Eckermann G, Heck J, Bleich S, Dabbert D, Grohmann R, Toto S. Das Blutungsrisiko unter Antidepressiva verstehen und einschätzen. Fortschr Neurol Psychiatr. 2023 Jun 16. doi: 10.1055/a-2089-3490.
Moschny N, Hefner G, Grohmann R, Eckermann G, Maier HB, Seifert J, Heck J, Francis F, Bleich S, Toto S, Meissner C. Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. Pharmaceuticals (Basel). 2021 May 27;14(6):514. doi: 10.3390/ph14060514.
Seifert J, Heck J, Eckermann G, Singer M, Bleich S, Grohmann R, Toto S. COVID-19-Impfung unter Psychopharmakotherapie. Psychiatr Prax. 2021 Nov;48(8):399-403. doi: 10.1055/a-1531-4460.
Seifert J, Heck J, Eckermann G, Singer M, Bleich S, Grohmann R, Toto S. Psychopharmakotherapie in Zeiten der COVID-19-Pandemie. Nervenarzt. 2020 Jul;91(7):604-610. doi: 10.1007/s00115-020-00939-4.
Glocker C, Grohmann R, Engel R, Seifert J, Bleich S, Stübner S, Toto S, Schüle C. Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015. Eur Arch Psychiatry Clin Neurosci. 2021 Dec;271(8):1425-1435. doi: 10.1007/s00406-021-01241-3.
Druschky K, Toto S, Bleich S, Baumgärtner J, Engel RR, Grohmann R, Maier HB, Neyazi A, Rudolph YJ, Rüther E, Schwörer H, Seifert J, Stübner S, Degner D. Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study. World J Biol Psychiatry. 2021 Jun;22(5):373-386. doi: 10.1080/15622975.2020.1819565.
Heck J, Seifert J, Stichtenoth DO, Schroeder C, Groh A, Szycik GR, Degner D, Adamovic I, Schneider M, Glocker C, Rüther E, Bleich S, Grohmann R, Toto S. A case series of serious and unexpected adverse drug reactions under treatment with cariprazine. Clin Case Rep. 2021 May 4;9(5):e04084. doi: 10.1002/ccr3.4084.
Zolk O, Greiner T, Schneider M, Heinze M, Dahling V, Ramin T, Grohmann R, Bleich S, Zindler T, Toto S, Seifert J. Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study. World J Biol Psychiatry. 2022 Jun;23(5):374-386. doi: 10.1080/15622975.2021.2011403.
Baumgärtner J, Grohmann R, Bleich S, Glocker C, Seifert J, Toto S, Rüther E, Engel RR, Stübner S. Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project. World J Biol Psychiatry. 2022 Feb;23(2):151-164. doi: 10.1080/15622975.2021.1938213.
Greil W, de Bardeci M, Seifert J, Bernegger X, Cattapan K, Stassen H, Wagner AL, Sieberer M, Grohmann R, Toto S. Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice. Hum Psychopharmacol. 2022 Jan;37(1):e2809. doi: 10.1002/hup.2809.
Reinhard MA, Seifert J, Greiner T, Toto S, Bleich S, Grohmann R. Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries. Eur Arch Psychiatry Clin Neurosci. 2021 Sep;271(6):1065-1076. doi: 10.1007/s00406-020-01223-x.
Seifert J, Engel RR, Bernegger X, Führmann F, Bleich S, Stübner S, Sieberer M, Greil W, Toto S, Grohmann R. Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017. J Affect Disord. 2021 Feb 15;281:547-556. doi: 10.1016/j.jad.2020.12.073.
Winkler D, Grohmann R, Friedrich ME, Toto S, Bleich S, Seifert J, Konstantinidis A, Shariat SF, Kasper S, Pjrek E. Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries. J Psychiatr Res. 2021 Dec;144:412-420. doi: 10.1016/j.jpsychires.2021.10.026.
Seifert J, Maier HB, Führmann F, Bleich S, Stübner S, Sieberer M, Bernegger X, Greil W, Schüle C, Toto S, Grohmann R, Reinhard MA. Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017. J Neural Transm (Vienna). 2022 Jul;129(7):925-944. doi: 10.1007/s00702-022-02504-6.
Friedrich, M. E., Grohmann, R., Rabl, U., Winkler, D., Konstantinidis, A., Engel, R., Seifert, J., Toto, S., Stübner, S., Frey, R., Kasper, S. Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016. International Journal of Neuropsychopharmacology 25, 556-566. https://doi: 10.1093/ijnp/pyac005
Reinhard, M. A., Seifert, J., Greiner, T., Toto, S., Bleich, S., & Grohmann, R. (2020). Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries. European Archives of Psychiatry and Clinical Neuroscience, 1-12.https://doi.org/10.1007/s00406-020-01223-x
Seifert, J., Engel, R. R., Bernegger, X., Führmann, F., Bleich, S., Stübner, S., ... & Grohmann, R. (2020). Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001–2017. Journal of Affective Disorders 281, 547-556 https://doi.org/10.1016/j.jad.2020.12.073
Druschky, K., Toto, S., Bleich, S., Baumgärtner, J., Engel, R.R., Grohmann, R., Maier, H.B., Neyazi, A., Rudolph, Y.J., Rüther, E., Schwörer, H., Seifert, J., Stübner, S.,& Degner, D. (2020) Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study. The World Journal of Biological Psychiatry 2020 Sep 28:1-14. https://doi.org/10.1080/15622975.2020
Schneider, M., Pauwels, P., Toto, S., Bleich, S., Grohmann, R., Heinze, M., & Greiner, T. (2020). Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016. European Neuropsychopharmacology 36, 60–71. https://doi.org/10.1016/j.euroneuro.2020.05.001
Mörkl, S., Seltenreich, D., Letmaier, M., Bengesser, S., Wurm, W., Grohmann, R., Bleich, S., Toto, S., Stübner, S., Butler, M. I., & Kasper, S. (2020). Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 21(4), 308–316. https://doi.org/10.1080/15622975.2019.1648871
Friedrich, M. E., Winkler, D., Konstantinidis, A., Huf, W., Engel, R., Toto, S., Grohmann, R., & Kasper, S. (2020). Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013. The International Journal of Neuropsychopharmacology, 23(2), 67–75. https://doi.org/10.1093/ijnp/pyz046
Druschky, K., Bleich, S., Grohmann, R., Engel, R. R., Toto, S., Neyazi, A., Däubl, B., & Stübner, S. (2020). Severe parkinsonism under treatment with antipsychotic drugs. European Archives of Psychiatry and Clinical neuroscience, 270(1), 35–47. https://doi.org/10.1007/s00406-019-01060-7
Greiner, T., Haack, B., Toto, S., Bleich, S., Grohmann, R., Faltraco, F., Heinze, M., & Schneider, M. (2020). Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016. European archives of psychiatry and clinical neuroscience, 270(1), 107–117. https://doi.org/10.1007/s00406-019-01058-1
Druschky, K., Bleich, S., Grohmann, R., Engel, R. R., Neyazi, A., Stübner, S., & Toto, S. (2019). Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 20(9), 732–741. https://doi.org/10.1080/15622975.2018.1500030
Toto, S., Grohmann, R., Bleich, S., Frieling, H., Maier, H. B., Greil, W., Cordes, J., Schmidt-Kraepelin, C., Kasper, S., Stübner, S., Degner, D., Druschky, K., Zindler, T., & Neyazi, A. (2019). Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study. The International Journal of Neuropsychopharmacology, 22(9), 560–573. https://doi.org/10.1093/ijnp/pyz037
Sanader, B., Grohmann, R., Grötsch, P., Schumann, T., Toto, S., Fernando, P., & Stübner, S. (2019). Clozapine-Induced DRESS Syndrome: A Case Series From the AMSP Multicenter Drug Safety Surveillance Project. Pharmacopsychiatry, 52(3), 156–159. https://doi.org/10.1055/a-0586-8983
Greiner, T., Schneider, M., Regente, J., Toto, S., Bleich, S., Grohmann, R., & Heinze, M. (2019). Priapism induced by various psychotropics: A case series. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 20(6), 505–512. https://doi.org/10.1080/15622975.2018.1520396
Greil, W., Zhang, X., Stassen, H., Grohmann, R., Bridler, R., Hasler, G., … Kasper, S. (2019). Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 29(1), 111–121. https://doi.org/10.1016/j.euroneuro.2018.10.010
Reinhard, M. A., Wilkening, A., Müller-Oerlinghausen, B., & Grohmann, R. (2019). Recurring Nephrotic Syndrome After Lithium Medication: A Case Report. Journal of Clinical Psychopharmacology, 39(5), 516–518. https://doi.org/10.1097/JCP.0000000000001078
Letmaier, M., Grohmann, R., Kren, C., Toto, S., Bleich, S., Engel, R., … Kasper, S. (2018). Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 19(3), 175–186. https://doi.org/10.1080/15622975.2017.1285048
Druschky, K., Bleich, S., Grohmann, R., Engel, R. R., Kleimann, A., Stübner, S., … Toto, S. (2018). Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study. European Archives of Psychiatry and Clinical Neuroscience, 268(2), 191–208. https://doi.org/10.1007/s00406-017-0827-5
Stübner, S., Grohmann, R., Greil, W., Zhang, X., Müller-Oerlinghausen, B., Bleich, S., … Neyazi, A. (2018). Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project. The International Journal of Neuropsychopharmacology, 21(9), 814–821. https://doi.org/10.1093/ijnp/pyy048
Druschky, K., Bleich, S., Grohmann, R., Burda, K., Frieling, H., Hillemacher, T., … Toto, S. (2018). Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries. European Psychiatry : The Journal of the Association of European Psychiatrists, 54, 117–123. https://doi.org/10.1016/j.eurpsy.2018.08.003
Schneider, M., Regente, J., Greiner, T., Lensky, S., Bleich, S., Toto, S., … Heinze, M. (2018). Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015. European Archives of Psychiatry and Clinical Neuroscience, 10.1007/s00406-018-0959–2. https://doi.org/10.1007/s00406-018-0959-2
Ladwig, J., Andreae, D., Grohmann, R., Toto, S., Kropp, S., & Bleich, S. (2017). New Onset of Suicidal Impulses Following Abrupt Cessation of Valproate. Pharmacopsychiatry, 50(6), 270. https://doi.org/10.1055/s-0043-109240
Glocker, C., Grohmann, R., & Schulz, H. (2017). Fatal Agranulocytosis Associated With Quetiapine in Monotherapy: A Case Report. Journal of Clinical Psychopharmacology, 37(5), 625–627. https://doi.org/10.1097/JCP.0000000000000752
Kleimann, A., Schrader, V., Stübner, S., Greil, W., Kahl, K. G., Bleich, S., … Toto, S. (2016). Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study. Journal of Affective Disorders, 191, 164–171. https://doi.org/10.1016/j.jad.2015.11.037
Friedrich, M.-E., Akimova, E., Huf, W., Konstantinidis, A., Papageorgiou, K., Winkler, D., … Kasper, S. (2016). Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program. The International Journal of Neuropsychopharmacology, 19(4), pyv126. https://doi.org/10.1093/ijnp/pyv126
Poppe, C., Müller, S. T., Greil, W., Walder, A., Grohmann, R., & Stübner, S. (2016). Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012. Journal of Affective Disorders, 200, 89–96. https://doi.org/10.1016/j.jad.2016.04.035
Laoutidis, Z.G., Konstantinidis, A., Grohmann, R., Luckhaus, C., Mobascher, J., & Cordes, J. (2015) Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project. Pharmacopsychiatry. 48(4-5):178-81 . doi: 10.1055/s-0035-1549997
Holl, A. K., Grohmann, R., Letmaier, M., Painold, A., Mörkl, S., Toto, S., & Kasper, S. (2015). Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011. European Archives of Psychiatry and Clinical Neuroscience, 265(3), 199–208. https://doi.org/10.1007/s00406-014-0523-7
Bridler, R., Häberle, A., Müller, S. T., Cattapan, K., Grohmann, R., Toto, S., … Greil, W. (2015). Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 25(6), 763–772. https://doi.org/10.1016/j.euroneuro.2015.03.017
Spindelegger, C. J., Papageorgiou, K., Grohmann, R., Engel, R., Greil, W., Konstantinidis, A., … Kasper, S. (2014). Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. The International Journal of Neuropsychopharmacology, 18(4), pyu080. https://doi.org/10.1093/ijnp/pyu080
Grohmann, R., Engel, R.R., Möller, H.J., Rüther, E., van der Velden, J.W., & Stübner, S. (2014) Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study. European Archives of Psychiatry and Clinical Neuroscience, 264(2):131-41. doi: 10.1007/s00406-013-0419-y
Köster, M., Grohmann, R., Engel, R.R., Nitsche, M.A., Rüther, E.,& Degner, D.(2013) Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008. Psychopharmacology (Berl), 230(2):191-201. doi: 10.1007/s00213-013-3281-8
Zorina, O. I., Haueis, P., Greil, W., Grohmann, R., Kullak-Ublick, G. A., & Russmann, S. (2013). Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients. Drug Safety, 36(4), 247–258. https://doi.org/10.1007/s40264-013-0027-9
Greil, W., Häberle, A., Schuhmann, T., Grohmann, R., & Baumann, P. (2013). Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland. Swiss Medical Weekly, 143, w13772–w13772. https://doi.org/10.4414/smw.2013.13772
Lange-Asschenfeldt, C., Kojda, G., Cordes, J., Hellen, F., Gillmann, A., Grohmann, R., & Supprian, T. (2013). Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients. Journal of Clinical Psychopharmacology, 33(6), 799–805. https://doi.org/10.1097/JCP.0b013e3182a4736f
Mundt, A. P., Aichberger, M. C., Fakhriddinov, S., Fayzirahmanova, M., Grohmann, R., Heinz, A., … Ströhle, A. (2012). Prescription patterns of patients diagnosed with schizophrenia in mental hospitals in Tashkent/Uzbekistan and in four German cities. Pharmacoepidemiology and Drug Safety, 21(2), 145–151. https://doi.org/10.1002/pds.2166
Letmaier, M., Painold, A., Holl, A. K., Vergin, H., Engel, R., Konstantinidis, A., … Grohmann, R. (2012). Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. The International Journal of Neuropsychopharmacology, 15(6), 739–748. https://doi.org/10.1017/S1461145711001192
Greil, W., Häberle, A., Haueis, P., Grohmann, R., & Russmann, S. (2012). Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. Journal of Affective Disorders, 136(3), 534–542. https://doi.org/10.1016/j.jad.2011.10.033
Haueis, P., Russmann, S., Zorina, O.I., Grohmann, R., Kullak-Ublick, G.A., Jaquenoud Sirot, E.,& Russmann H.(2012) Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008. Pharmacopsychiatry,45(4):127-32. doi: 10.1055/s-0031-1291348
Haueis, P., Greil, W., Huber, M., Grohmann, R., Kullak-Ublick, G.A., & Russmann, S. (2011) Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software. Clinical Pharmacology& Therapy. 90(4):588-96. doi: 10.1038/clpt.2011.150
Letmaier, M., Painold, A., Holl, A. K., Grohmann, R., & Vergin, H. (2012). Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone. International Journal of Psychiatry in Clinical Practice, 16(2), 153–156. https://doi.org/10.3109/13651501.2011.644300
Konstantinidis, A., Papageorgiou, K., Grohmann, R., Horvath, A., Engel, R., & Kasper, S. (2012) Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program. International Journal of Neuropsychopharmacology, 15(4):449-57. doi: 10.1017/S1461145711000745.
Haeberle, A., Greil, W., Russmann, S., & Grohmann, R. (2012). Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP. BMC Psychiatry, 12, 153. https://doi.org/10.1186/1471-244X-12-153
Mundt, A. P., Fakhriddinov, S., Fayzirahmanova, M., Aichberger, M. C., Ivens, S., Schouler-Ocak, M., … Ströhle, A. (2011). Use of psychiatric inpatient capacities and diagnostic practice in Tashkent/Uzbekistan as compared to Berlin/Germany. Social Psychiatry and Psychiatric Epidemiology, 46(12), 1295–1302. https://doi.org/10.1007/s00127-010-0299-7
Mundt, A., Ströhle, A., Heimann, H., Heinz, A., & Grohmann, R. (2010). Pharmacoepidemiology of patients hospitalized for somatoform disorders in psychiatric hospitals and departments. Pharmacoepidemiology and Drug Safety, 19(7), 687–693. https://doi.org/10.1002/pds.1976
Stübner, S., Grohmann, R., von Stralendorff, I., Rüther, E., Möller, H.-J., Müller-Oerlinghausen, B., Horvath, A., & Greil, W. (2010). Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project. The Journal of Clinical Psychiatry, 71(10), 1293–1307. https://doi.org/10.4088/JCP.09m05912blu
Lange-Asschenfeldt, C., Grohmann, R., Lange-Asschenfeldt, B., Engel, R. R., Rüther, E., & Cordes, J. (2009). Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program. The Journal of Clinical Psychiatry, 70(9), 1258–1265. https://doi.org/10.4088/JCP.08m04563
Wolfsperger, M., Greil, W., Rössler, W., & Grohmann, R. (2007). Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. Journal of Affective Disorders, 99(1–3), 9–17. https://doi.org/10.1016/j.jad.2006.08.017
Conca, A., Grohmann, R., Di Pauli, J., & Hausmann, A. (2007). Is there a rationale in combining anticonvulsants for bipolar patients? Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 21(2), 159–171. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17640500
Mobascher, J., Zielasek, J., Schuier, F.J., Mobascher, A., Grohmann, R., Agelink, M.W., & Cordes, J. (2005) Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report. Pharmacopsychiatry, 38(6):329-30. doi:10.1055/s-2005-916191.
Heinze, M., Andreae, D., & Grohmann, R. (2005) Pharmacotherapy of personality disorders in German speaking countries: state and changes in the last decade. Pharmacopsychiatry,38(5):201-5. doi: 10.1055/s-2005-873154.
Zullino, D., Mayland, G., Schmidt, L.G., Fähndrich, E., Greil, W., Horvath, A., Rüther, E., Engel, R., Hippius, H.,& Baumann, P.(2005) Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences. International Journal of Clinical Pharmacology and Therapeutics. 43(7):339-49. doi: 10.5414/cpp43339.
Degner, D., Kropp, S., Porzig, J., Grohmann, R., & Rüther, E.(2005) Pseudohallucinations associated with moclobemide: a case report. Pharmacopsychiatry. 38(4):179-81. doi: 10.1055/s-2005-871242.
Cordes, J., Streit, M., Loeffler, S., von Wilmsdorff, M., Agelink, M., & Klimke, A. (2004) Reversible neutropenia during treatment with olanzapine: three case reports.The World Journal of Biological Psychiatry.5(4):230-4. doi: 10.1080/15622970410029938.
Kropp, S., Ziegenbein, M., Grohmann, R., Engel, R.R., & Degner, D. 2004) Galactorrhea due to psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S84-8. doi:10.1055/s-2004-815515.
Kropp, S., Grohmann, R., Hauser, U., Rüther, E., & Degner D. (2004) Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project. Pharmacopsychiatry. 37 Suppl 1:S79-83. doi: 10.1055/s-2004-815514.
Stübner,S., Grohmann, R., Engel, R., Bandelow, B., Ludwig, W.D., Wagner, G., Müller- Oerlinghausen, B., Möller, H.J, Hippius, H., & Rüther,E. (2004) Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S70-8. doi:10.1055/s-2004-815513
Schmid, C., Grohmann, R., Engel, R.R., Rüther, E.,& Kropp, S. (2004) Cardiac adverse effects associated with psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S65-9. doi: 10.1055/s-2004-815512.
Stübner, S., Rustenbeck, E., Grohmann, R., Wagner, G., Engel, R., Neundörfer, G., Möller, H.J., Hippius, H., & Rüther, E. (2004) Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S54-64. doi: 10.1055/s-2004-815511
Bender, S., Grohmann, R., Engel, R.R., Degner, D., Dittmann-Balcar, A., & Rüther, E. (2004) Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry, 37 Suppl 1:S46-53. doi: 10.1055/s-2004-815510.
Degner, D., Grohmann, R., Kropp, S., Rüther, E., Bender, S., Engel, R.R., & Schmidt, L.G. (2004) Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry. 37 Suppl 1:S39-45. doi: 10.1055/s-2004-815509.
Grohmann, R., Engel, R.R., Geissler, K.H., & Rüther, E. (2004) Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Pharmacopsychiatry. 37 Suppl 1:S27-38. doi: 10.1055/s-2004-815508.
Engel,R.R., Grohmann, R., Rüther, E., & Hippius, H. (2004) Research methods in drug surveillance. Pharmacopsychiatry. 37 Suppl 1:S12-5. doi: 10.1055/s-2004-815506.
Grohmann, R., Engel, R.R., Rüther, E., & Hippius, H. (2004) The AMSP drug safety program: methods and global results. Pharmacopsychiatry. 37 Suppl 1:S4-11. doi: 10.1055/s-2004-815505.
Degner, D., Grohmann, R., Bleich, S., & Rüther, E. (2000) Neue Antidepressiva. Mit welchen Nebenwirkungen und Interaktionen müssen Sie rechnen? [New antidepressant drugs. What side effects and interactions are to be expected?]. MMW Fortschritte der Medizin, 142(49-50):35-8, 40.
Grohmann, R., Rüther, E., Engel, R.R., Hippius, H. (1999). Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiatry. 32(1):21-8. doi: 10.1055/s-2007-979184.